Beijing Hotgen Biotech Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-191	28.92	944.74	2,186
Depreciation & Amortization	89.05	70.53	120.29	68.34
Other Amortization	15.77	7.76	28.15	5.38
Loss (Gain) From Sale of Assets	1.63	0.64	0.34	14.21
Asset Writedown & Restructuring Costs	55.15	36.95	70.06	8.51
Loss (Gain) From Sale of Investments	9.36	23.68	-10.91	-24.88
Provision & Write-off of Bad Debts	1.36	-13.4	11.34	0.7
Other Operating Activities	24.39	-59.57	94.17	118.58
Change in Accounts Receivable	-77.16	93.75	-22.28	-81.52
Change in Inventory	47.59	123.21	36.03	-213.43
Change in Accounts Payable	3.31	-284.98	-242.99	564.77
Change in Other Net Operating Assets	-24.34	-71.27	-32.27	8.46
Operating Cash Flow	-37.16	-48.53	978.75	2,644
Operating Cash Flow Growth	-	-	-62.99%	1506.38%
Capital Expenditures	-51.41	-413.37	-565.21	-398.86
Sale of Property, Plant & Equipment	1.19	3.74	0.58	0.13
Divestitures	-7.89	-17.11	-0.08	-
Investment in Securities	130.21	238.61	-602.42	-1,367
Other Investing Activities	38.74	26.56	17.08	22.34
Investing Cash Flow	110.83	-161.57	-1,130	-1,763
Long-Term Debt Repaid	-5.12	-27.24	-32.29	-11.4
Total Debt Repaid	-5.12	-27.24	-32.29	-11.4
Net Debt Issued (Repaid)	-5.12	-27.24	-32.29	-11.4
Issuance of Common Stock	45.02	3.34	-	-
Repurchase of Common Stock	-92.03	-16.44	-150.04	-
Common Dividends Paid	-17.34	-	-310.98	-93.29
Other Financing Activities	-10	3.8	8.32	9.63
Financing Cash Flow	-79.48	-36.55	-484.99	-95.07
Foreign Exchange Rate Adjustments	-0.15	-0.46	5.2	-14.83
Net Cash Flow	-5.96	-247.11	-631.09	771.69
Free Cash Flow	-88.57	-461.9	413.54	2,246
Free Cash Flow Growth	-	-	-81.58%	-
Free Cash Flow Margin	-17.34%	-84.31%	11.63%	41.82%
Free Cash Flow Per Share	-0.96	-5.23	4.50	24.40
Cash Income Tax Paid	8.39	20.06	371.82	312.86
Levered Free Cash Flow	36.2	-561.63	129.6	1,644
Unlevered Free Cash Flow	36.48	-561	131.05	1,645
Change in Working Capital	-42.87	-144.05	-279.43	267.89

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.